Legal Representation
Attorney
Mark Lerner
USPTO Deadlines
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 5, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 5, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 23, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 22, 2010 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Nov 18, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 18, 2010 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 25, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 24, 2010 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 20, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 20, 2010 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 8, 2010 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 8, 2010 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 1, 2009 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 24, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 24, 2009 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 19, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 19, 2009 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 29, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 29, 2009 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 2, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 2, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 2, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 3, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 11, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 20, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 5, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 31, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 31, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 31, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 31, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 31, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 28, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 28, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 28, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 30, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 30, 2007 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | Loading... |
| Nov 29, 2007 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Nov 29, 2007 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Nov 29, 2007 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Nov 16, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 15, 2007 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Aug 14, 2007 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of opioid dependence
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word "SUBOXONE" in blue with a green petal over the "ON" in "SUBOXONE". The chemical name of the mark ("Buprenorphine HCI/Naloxone HCI Dihydrate") appears in black underneath the word "SUBOXONE". To the right of the chemical name is a stylized "C" with three vertical lines inside, followed by the words "sublingual tablets" all in the color black.
Color Claim
The color(s) blue, green, and black is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE" AND A STYLIZED "C" WITH THREE VERTICAL LINES INSIDE AND "SUBLINGUAL TABLETS"